- Global Pharma News & Resources

Global Pharmaceutical Continuous Manufacturing Market (2021 to 2028) - Featuring Pfizer, Glatt & Syntegon Among Others -

DUBLIN--(BUSINESS WIRE)--The "Global Pharmaceutical Continuous Manufacturing Market 2021-2028" report has been added to's offering.

This report insinuates that the global pharmaceutical continuous manufacturing market is likely to showcase an upward trend at a CAGR of 10.35% over the estimated period 2021-2028.

Factors such as the surge in initiatives by regulatory authorities for the adoption of continuous manufacturing, coupled with the growing acceptance of PCM systems, are stimulating the global market's growth. Further, the increasing opportunities in the untapped emerging economies and the rise in large molecules and biologics manufacturing, are opening new avenues for the pharmaceutical continuous manufacturing market.

However, the lack of demand for pharmaceutical continuous manufacturing systems in underdeveloped countries and growing consumer expectations pertaining to better medicines, are restricting the global market's development to a large extent.

The global pharmaceutical continuous manufacturing market comprises the regions of North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa.

The Asia-Pacific is projected to become the fastest-growing market for pharmaceutical continuous manufacturing during the assessed period. The region's growth can be attributed to growing investments in the pharmaceutical and biopharmaceutical industry, along with the rising contract research organization. Additionally, the surging concentration of prominent manufacturers on extending their operations in the emerging countries is creating multiple opportunities across the APAC region.

In China, favorable policies to promote the healthcare sector are likely to boost the pharmaceutical companies. Moreover, several companies are striving to conduct continuous bioprocessing, thereby strengthening the pharmaceutical continuous manufacturing market in China.

Companies Mentioned

  • Hosokawa Micron Corporation
  • GEA Group AG
  • LB Bohle Maschinen + Verfahren GmbH
  • Thermofisher Scientific Inc
  • Siemens Healthineers
  • Eli Lilly & Company
  • Pfizer Inc
  • Glatt GmbH
  • Syntegon (Formerly Bosch Packaging Technology)
  • Gebruder Lodige Maschinenbau GmbH
  • Korsch AG
  • Coperion GmbH
  • Munson Machinery Company

Key Topics Covered:

1. Global Pharmaceutical Continuous Manufacturing Market - Summary

2. Industry Outlook

2.1. Porter's Five Forces Model

2.1.1. Threat of New Entrants

2.1.2. Threat of Substitute Products

2.1.3. Bargaining Power of Buyers

2.1.4. Bargaining Power of Suppliers

2.1.5. Competitive Rivalry

2.2. Impact of Covid-19 on Pharmaceutical Continuous Manufacturing Market

2.3. Legal, Policy, & Regulatory Framework

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Key Insights

2.7. Market Drivers

2.7.1. Rise in Initiatives by Regulatory Authorities for the Adoption of Continuous Manufacturing

2.7.2. Surging Acceptance of Pharmaceutical Continuous Manufacturing Systems

2.7.3. Rising Healthcare Expenditure

2.8. Market Restraints

2.8.1. Lack of Demand for Pcm Systems in Underdeveloped Economies

2.8.2. Rising Customer Expectations for Better Medicines

2.9. Market Opportunities

2.9.1. Increasing Opportunities in the Untapped Emerging Economies

2.9.2. Surge in the Manufacturing of Large Molecules and Biologics

3. Global Pharmaceutical Continuous Manufacturing Market Outlook - by Product

3.1. Integrated Continuous System

3.2. Semi-Continuous System

3.3. Control & Software

4. Global Pharmaceutical Continuous Manufacturing Market Outlook - by Application

4.1. Final Drug Product Manufacturing

4.2. Api Manufacturing

5. Global Pharmaceutical Continuous Manufacturing Market Outlook - by End-User

5.1. Pharmaceutical Companies

5.2. Contract Manufacturing Organizations

5.3. Other End-Users

6. Global Pharmaceutical Continuous Manufacturing Market - Regional Outlook

6.1. North America

6.2. Europe

6.3. Asia-Pacific

6.4. Latin America

6.5. Middle East and Africa

7. Company Profile

8. Research Methodology & Scope

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 08-Feb-2021